[Re(bpy-tBu)(CO)4](OTf) (bpy-tBu = 4,4'-di-tert-butyl-2,2'-bipyridine, OTf = trifluoromethanesulfonate) (1) and [Re(bpy)(CO)4](OTf) (bpy = 2,2'-bipyridine) (2) were synthesized and studied as proposed intermediates in the electrocatalytic reduction of carbon dioxide (CO2) by Re(bpy-R)(CO)3X. Both compounds demonstrated increased current responses in cyclic voltammograms under CO2. Complex 1 was also characterized by X-ray crystallography. Infrared-spectroelectrochemistry (IR-SEC) of 1 and 2 indicated that upon exposure of the cationic tetracarbonyl compounds to a reducing potential, a CO ligand is labilised and [Re(bpy-R)(CO)3(CH3CN)](+) species are formed. This is proposed to occur via an electron-transfer-catalysed process wherein a catalytic amount of reduced species propagates a ligand exchange reaction. Addition of a catalytic amount of potassium intercalated graphite (KC8), a chemical reductant, to a solution of 1 or 2 also yielded quantitative formation of [Re(bpy-R)(CO)3(CH3CN)](+), which indicates that the CO loss is catalysed by electron transfer, and not the electrode itself.
No takes yet. Share an insight, caveat, or question.
Grice et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: